Integrated Proteomic and Transcriptomic-Based Approaches to Identifying Signature Biomarkers and Pathways for Elucidation of Daoy and UW228 Subtypes
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Patient survival has remained largely the same for the past 20 years, with therapies causing significant health, cognitive, behavioral and developmental complications for those who survive the tumor. In this study, we profiled...
Main Authors: | Roger Higdon, Jessie Kala, Devan Wilkins, Julia Fangfei Yan, Manveen K. Sethi, Liang Lin, Siqi Liu, Elizabeth Montague, Imre Janko, John Choiniere, Natali Kolker, William S. Hancock, Eugene Kolker, Susan Fanayan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | Proteomes |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-7382/5/1/5 |
Similar Items
-
Creating Educational Trifold Brochures from Microsoft Word® Templates: An Example from the Florida Master Naturalist Program
by: Martin B. Main, et al.
Published: (2006-08-01) -
High expression of DNA methyltransferases in primary human medulloblastoma
by: Tímea Pócza, et al.
Published: (2016-06-01) -
Rare cases of medulloblastoma with hypermutation
by: Aditi Bagchi, et al.
Published: (2022-05-01) -
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
by: Lidia Gatto, et al.
Published: (2022-01-01) -
YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells
by: Gustavo Alencastro Veiga Cruzeiro, et al.
Published: (2021-12-01)